CDMO News
Syngene Acquires First US Biologics Facility from Emergent BioSolutions
Syngene International Ltd. has announced the acquisition of its first biologics facility in the United States, marking a strategic expansion in its global footprint. The facility, purchased from Emergent Manufacturing Operations Baltimore, LLC, a subsidiary of Emergent BioSolutions Inc., will enhance Syngene’s
11 March 2025
Stay ahead of trends and best practices
